Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block

• Status: Not yet recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The goal of the study is to compare the duration of analgesia in patients undergoing forearm or hand surgery with a supraclavicular brachial plexus block, who receive either iv dexmedetomidine or placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hôpital du Valais
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

Patients undergoing elbow, forearm or hand surgery under supraclavicular brachial plexus block Patients who are ASA physical status I-III

Exclusion criteria

• Patient refusal

• ASA physical status IV

• History of hypersensitivity or intolerance to dexmedetomidine

• History of hypersensitivity or intolerance to dexamethasone

• History of hypersensitivity or intolerance to local anesthetics

• History of recent (< 1 year) cerebrovascular insult

• Second or third degree heart block

• Uncontrolled hypotension

• Conditions contraindicating supraclavicular brachial plexus block: neurological deficit or neuropathy of the arm, severe hepatic dysfunction (Child B and C), coagulopathy, malignancy or infection in the area above the clavicle

• Chronic opioid use

• Pregnancy